The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Extended interval dosing in patients with cancer receiving immune checkpoint inhibitors: Safety analysis from the EDICI study.
 
Luca Cantini
No Relationships to Disclose
 
Francesco Paoloni
No Relationships to Disclose
 
Federica Pecci
No Relationships to Disclose
 
Francesco Spagnolo
Consulting or Advisory Role - MSD; Novartis; Philogen; Pierre Fabre; Sun Pharma
 
Sophie Aerts
No Relationships to Disclose
 
Alice Indini
Research Funding - MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Sara Fancelli
No Relationships to Disclose
 
Fabrizio Citarella
No Relationships to Disclose
 
Mattia Garutti
Consulting or Advisory Role - Daiichi Sankyo; Lilly; Novartis
 
Maria Chiara Sergi
No Relationships to Disclose
 
Raffaele Giusti
No Relationships to Disclose
 
Anna Maria Di Giacomo
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Incyte; Merck; Novartis; Pierre Fabre; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pierre Fabre
 
Antonello Veccia
No Relationships to Disclose
 
Diego Luigi Cortinovis
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Novartis; Roche/Genentech
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
Rita Leporati
No Relationships to Disclose
 
Ilaria Mariangela Scaglione
No Relationships to Disclose
 
Francesco Atzori
No Relationships to Disclose
 
Lucia Festino
No Relationships to Disclose
 
Joachim Aerts
Stock and Other Ownership Interests - amphera
Consulting or Advisory Role - Amphera; AstraZeneca; BIOCAD; Bristol-Myers Squibb; Lilly; MSD Oncology
Research Funding - Lilly (Inst)
Patents, Royalties, Other Intellectual Property - cdendritic cel based immunotherapy (Inst); combination immunotherapy (Inst); proteomics in nsclc (Inst)
 
Rossana Berardi
Consulting or Advisory Role - Amgen; AstraZeneca (Inst); Boehringer Ingelheim; Eisai; GlaxoSmithKline; Lilly; MSD Oncology (Inst); Novartis (Inst); Otsuka; Roche (Inst)